Galidesivir structure
|
Common Name | Galidesivir | ||
---|---|---|---|---|
CAS Number | 249503-25-1 | Molecular Weight | 265.268 | |
Density | 1.6±0.1 g/cm3 | Boiling Point | 661.2±55.0 °C at 760 mmHg | |
Molecular Formula | C11H15N5O3 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 353.7±31.5 °C |
Use of GalidesivirGalidesivir (BCX 4430) is a viral RNA-dependent RNA polymerase (RdRp) inhibitor; demonstrated broad-spectrum activity in multiple viruses and a favorable preliminary preclinical safety profile. |
Name | BCX4430 freebase |
---|---|
Synonym | More Synonyms |
Description | Galidesivir (BCX 4430) is a viral RNA-dependent RNA polymerase (RdRp) inhibitor; demonstrated broad-spectrum activity in multiple viruses and a favorable preliminary preclinical safety profile. |
---|---|
Related Catalog | |
Target |
RdRp |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 661.2±55.0 °C at 760 mmHg |
Molecular Formula | C11H15N5O3 |
Molecular Weight | 265.268 |
Flash Point | 353.7±31.5 °C |
Exact Mass | 265.117493 |
LogP | -3.03 |
Vapour Pressure | 0.0±2.1 mmHg at 25°C |
Index of Refraction | 1.782 |
Storage condition | 2-8℃ |
(2S,3S,4R,5R)-2-(4-Amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-(hydroxymethyl)-3,4-pyrrolidinediol |
MFCD28385877 |
BCX4430 |
UNII:OLF97F86A7 |
(2S,3S,4R,5R)-2-(4-amino- 5H-pyrrolo[3,2-d]pyrimidin- 7-yl)-5-(hydroxymethyl) pyrrolidine-3,4-diol |
3,4-Pyrrolidinediol, 2-(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-(hydroxymethyl)-, (2S,3S,4R,5R)- |
Galidesivir |
OLF97F86A7 |
Immucillin-A |
BCX4430 (freebase) |